NCT04994964

Brief Summary

Almost half of newborns undergoing surgery to repair narrowing or interruption of the aortic arch will suffer injury to the recurrent laryngeal nerve. This causes a weak voice and can lead to problems with feeding including aspiration of milk feed after the surgery. As these children can have a vulnerable circulation, aspiration events can reduce survival and poor weight gain has been shown to correlate with poorer outcomes after surgery. In other types of surgery in the neck, monitors can be used to alert the surgeon to when injury is occurring to the recurrent nerve. To date, this type of monitoring has not been possible in newborns. This study aims to investigate if this type of monitoring is feasible in newborns undergoing aortic arch repair, to prevent recurrent nerve injury.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

March 23, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

August 6, 2021

Status Verified

April 1, 2021

Enrollment Period

1.1 years

First QC Date

March 11, 2021

Last Update Submit

August 5, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • Vocal cord EMG - Burst amplitude (mV)

    Feasibility of performing vocal cord EMG during neonatal arch repair

    Intra-operative (1 hour)

  • Vocal cord EMG - Burst duration (ms)

    Feasibility of performing vocal cord EMG during neonatal arch repair

    Intra-operative (1 hour)

  • Vocal cord EMG - Burst frequency (Hz)

    Feasibility of performing vocal cord EMG during neonatal arch repair

    Intra-operative (1 hour)

  • Vocal cord EMG - Interburst interval (ms)

    Feasibility of performing vocal cord EMG during neonatal arch repair

    Intra-operative (1 hour)

  • Vocal cord EMG - Signal to noise ratio (mV)

    Feasibility of performing vocal cord EMG during neonatal arch repair

    Intra-operative (1 hour)

  • Correlation of Vocal cord EMG with post-operative palsy

    Vocal cord ultrasound

    Post extubation / 1 week post-operatively

Secondary Outcomes (1)

  • Neuromuscular blockade

    Intra-operative (1 hour)

Interventions

ElectromyographyDIAGNOSTIC_TEST

Needle vocal cord electromyography using Medtronic NIM monitor

Eligibility Criteria

Age0 Days - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Only patients with parents/ carers able to give informed consent to participation in the trial will be included. • Male and female patients will be included
  • Only Neonates (babies less than 28 days of age) will be included in the study.
  • Only patients undergoing repair of the aortic arch via median sternotomy will be included in the study

You may not qualify if:

  • Patients with severe abnormalities of the airway, such that they are unlikely to be extubated within 7 days of the aortic arch repair surgery will be excluded from participation, as assessment of vocal cord function will be difficult/ impossible in such patients.
  • Patients with parents/ carers who are unable to give informed consent to participation in the trial will be excluded from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birmingham Children's Hospital

Birmingham, West Midlands, B4 6NH, United Kingdom

RECRUITING

MeSH Terms

Conditions

Recurrent Laryngeal Nerve Injuries

Interventions

Electromyography

Condition Hierarchy (Ancestors)

Laryngeal Nerve InjuriesLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve InjuriesCranial Nerve InjuriesCranial Nerve DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

ElectrodiagnosisDiagnostic Techniques and ProceduresDiagnosisMyography

Study Officials

  • Phil Botha, PhD

    Birmingham Women's and Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Phil Botha, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2021

First Posted

August 6, 2021

Study Start

March 23, 2021

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

August 6, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations